ATLASNiagen Bioscience (NAGE) earnings date: Nov 4, 2026
Niagen Bioscience (NAGE) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 4, 2026, after the close. Analysts expect EPS of $0.00.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on NAGE
| Last price | $2.38 (+2.2%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.1% |
| Earnings beat history | Beat the EPS estimate in 4 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Niagen Bioscience stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Niagen Bioscience reports on Nov 4, 2026. One email the day before, with ATLAS’s read on Niagen Bioscience. You can switch it off at any time.
Alert me before NAGE reportsFree to start. Creating an account takes under a minute.
Notify me when Niagen Bioscience reports
Track NAGE free Add Niagen Bioscience to a free ATLAS watchlist and see its next report date in one place.
NAGE earnings at a glance
| Next report (confirmed) | Wed, Nov 4, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | $0.00 |
| Last report | Aug 4, 2026 · Beat |
| Beat rate (last 5 reports) | 4 of 5 (80%) |
| Average EPS surprise | +39.8% |
| Average move around a report | ±7.2% (last 5) |
| Sector | Consumer Defensive · Packaged Foods |
Niagen Bioscience earnings history: last 5 reports
Niagen Bioscience last reported on Aug 4, 2026: EPS of $0.01 against an estimate of -$0.01 (+200.0% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 4, 2026 | -$0.01 | $0.01 | +200.0% | Beat | -16.2% |
| May 6, 2026 | $0.06 | $0.02 | -66.7% | Miss | -13.1% |
| Mar 4, 2026 | $0.02 | $0.03 | +50.0% | Beat | +4.7% |
| Feb 12, 2026 | $1.03 | $1.07 | +3.9% | Beat | +0.6% |
| Jan 13, 2026 | $1.36 | $1.52 | +11.8% | Beat | -1.3% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for NAGE
See the fair value, the probability range and the earnings history of Niagen Bioscience on its ATLAS page.
Niagen Bioscience (NAGE) stock analysisPlans from €3.99 a month.
Niagen Bioscience earnings: frequently asked questions
When does Niagen Bioscience (NAGE) report earnings?
Niagen Bioscience is scheduled to report on Wednesday, November 4, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for NAGE?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is $0.00 per share (USD). Estimates can change before the report.
How often does NAGE beat earnings estimates?
Of its last 5 reports with a recorded result, Niagen Bioscience beat the EPS estimate 4 times; the average surprise was +39.8%. Past results do not predict the next one.
How much does NAGE move around earnings?
Over its last 5 reports the stock moved an average of 7.2% (absolute, from the close before the report day to the close after it), and finished higher 2 of 5 times.
Did Niagen Bioscience beat earnings estimates last quarter?
Niagen Bioscience last reported on Aug 4, 2026: EPS of $0.01 against an estimate of -$0.01 (+200.0% surprise), a beat.
How much does NAGE usually move in a day?
On a normal trading day the ATLAS model puts NAGE’s one-day range at about ±3.1%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 4, 2026
Educational information, not investment advice. Disclaimer